AstraZeneca plc's (AZN) Buy Rating Reaffirmed at Berenberg Bank

AstraZeneca plc's (AZN) Buy Rating Reaffirmed at Berenberg Bank


's stock had its "buy" rating restated by Berenberg Bank in a research report issued on Tuesday. They currently have a GBX 5,500 price target on the biopharmaceutical company's stock.



from Biotech News